We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMH icon
1251
VanEck Semiconductor ETF
SMH
$60.8B
$169K ﹤0.01%
688
-100
-13% -$24.3K
SCHM icon
1252
Schwab US Mid-Cap ETF
SCHM
$14.2B
$167K ﹤0.01%
6,024
– –
TEF
1253
DELISTED
Telefonica
TEF
$166K ﹤0.01%
34,252
+1,388
+4% +$6.31K
ORAN
1254
DELISTED
Orange
ORAN
$164K ﹤0.01%
14,294
+4,136
+41% +$46.9K
SPYM
1255
State Street SPDR Portfolio S&P 500 ETF
SPYM
$157B
$159K ﹤0.01%
2,352
– –
ESGD icon
1256
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
$158K ﹤0.01%
1,880
– –
NMR icon
1257
Nomura Holdings
NMR
$28.3B
$158K ﹤0.01%
30,261
+2,657
+10% +$15.1K
SLYG icon
1258
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5B
$154K ﹤0.01%
1,658
– –
IHI icon
1259
iShares US Medical Devices ETF
IHI
$3.17B
$153K ﹤0.01%
2,585
– –
DFAC icon
1260
Dimensional US Core Equity 2 ETF
DFAC
$47B
$150K ﹤0.01%
4,380
– –
DGT icon
1261
State Street SPDR Global Dow ETF
DGT
$605M
$150K ﹤0.01%
1,085
– –
PSO icon
1262
Pearson
PSO
$10.6B
$149K ﹤0.01%
+10,983
New +$147K
RSPT icon
1263
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.31B
$149K ﹤0.01%
3,950
– –
IYJ icon
1264
iShares US Industrials ETF
IYJ
$1.95B
$147K ﹤0.01%
1,100
– –
KYN icon
1265
Kayne Anderson Energy Infrastructure Fund
KYN
$2.42B
$146K ﹤0.01%
+13,249
New +$141K
TAK icon
1266
Takeda Pharmaceutical
TAK
$56.7B
$145K ﹤0.01%
10,192
-6,307
-38% -$89.5K
BGC icon
1267
BGC Group
BGC
$5.64B
$143K ﹤0.01%
15,550
+703
+5% +$6.57K
XLG icon
1268
Invesco S&P 500 Top 50 ETF
XLG
$10.2B
$138K ﹤0.01%
2,900
– –
IGPT icon
1269
Invesco AI and Next Gen Software ETF
IGPT
$1.08B
$137K ﹤0.01%
+3,000
New +$134K
AIQ icon
1270
Global X Artificial Intelligence & Technology ETF
AIQ
$8.89B
$136K ﹤0.01%
3,671
+1,400
+62% +$49.2K
EIS icon
1271
iShares MSCI Israel ETF
EIS
$863M
$130K ﹤0.01%
1,931
– –
PBE icon
1272
Invesco Biotechnology & Genome ETF
PBE
$286M
$130K ﹤0.01%
1,860
– –
FWONK icon
1273
Liberty Media Series C
FWONK
$25.5B
$130K ﹤0.01%
1,676
-382
-19% -$29.4K
SPTM icon
1274
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.3B
$128K ﹤0.01%
1,829
– –
PARA
1275
DELISTED
Paramount Global Class B
PARA
$127K ﹤0.01%
+11,952
New +$130K
49 50
51
52 53

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.